LASSOGEN

lassogen-logo

Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines. Lassogen was founded in 2019 to unlock the full potential of lasso peptides as a new therapeutic modality for diagnosing and treating some of our most intractable health challenges. The company is the result of a convergence of technological advances that have opened the door to a vast, new, untapped source of novel medicines.

#SimilarOrganizations #People #Financial #Website #More

LASSOGEN

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2019-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.lassogen.com

Total Employee:
1+

Status:
Active

Total Funding:
4.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network


Similar Organizations

casma-therapeutics-logo

Casma Therapeutics

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

trefoil-therapeutics-logo

Trefoil Therapeutics

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.


Current Advisors List

phyllis-whiteley_image

Phyllis Whiteley Board Member @ Lassogen
Board_member
2020-09-01

Current Employees Featured

mark-burk_image

Mark Burk
Mark Burk Founder, President & CEO @ Lassogen
Founder, President & CEO
2019-10-01

kent-boles_image

Kent Boles
Kent Boles Co-founder and Head of R&D @ Lassogen
Co-founder and Head of R&D
2019-09-01

hiroko-masamune_image

Hiroko Masamune
Hiroko Masamune Chief Development Officer @ Lassogen
Chief Development Officer
2020-06-01

Founder


kent-boles_image

Kent Boles

mark-burk_image

Mark Burk

Investors List

first-in-ventures_image

First In Ventures

First In Ventures investment in Seed Round - Lassogen

tsingyuan-ventures_image

Foothill Ventures

Foothill Ventures investment in Seed Round - Lassogen

playground-global_image

Playground Global

Playground Global investment in Seed Round - Lassogen

better-ventures_image

Better Ventures

Better Ventures investment in Seed Round - Lassogen

Official Site Inspections

http://www.lassogen.com

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Lassogen"

Lassogen , Inc.

By leveraging infinite diversity and tunable properties, we are able to optimize our potent, selective, stable, safe, and efficacious lasso therapeutics, which we call Lassotides™. Learn …See details»

Lassogen - Crunchbase Company Profile & Funding

Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines. Lassogen was founded in 2019 to unlock the full potential of lasso peptides as a …See details»

Meet The Team - Lassogen

Lassogen's mission is to unlock the full potential of our engineered Lassotides™ as a new therapeutic modality for diagnosing and treating some of our most intractable health …See details»

Lassogen, Inc.

I am writing to tell my story of the founding of Lassogen, a biotech start-up company that is dedicated to advancing novel therapeutics based on lasso peptides. I was originally trained as an organic chemist but have spent the …See details»

Lassogen, Inc. - LinkedIn

Lassogen is developing a new therapeutic modality based on lasso peptides that we are programming to treat difficult diseases such as cancer and autoimmune disorders. Lasso …See details»

RePORT 〉 RePORTER - National Institutes of Health

Lassogen is developing LAS-103 as a stable, potent, and selective ETBR antagonist that enhances leukocyte influx into the TME and renders tumors more susceptible to …See details»

Lassogen - Org Chart, Teams, Culture & Jobs - The Org

Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines. It takes less than ten minutes to set up your company page. View Lassogen's up-to …See details»

Lassogen - Funding, Financials, Valuation & Investors - Crunchbase

Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines.See details»

Lassogen Company Profile - Office Locations, Competitors ... - Craft

Lassogen is a company developing lasso peptides. They are naturally produced by bacteria and represent a source of molecular diversity for drug discovery and development. Lassogen $4.5 …See details»

Lassogen - Technology

These custom-engineered lasso peptides are called Lassotides™. Using cutting-edge synthetic biological techniques combined with sophisticated fermentation methodologies, large quantities of lassotides can be manufactured. peptides …See details»

LASSOGEN, INC. Company Profile | San Diego, CA | Competitors ...

Find company research, competitor information, contact details & financial data for LASSOGEN, INC. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

Lassogen - VentureRadar

Develops lasso peptide therapeutics for diagnosing and treating intractable health challenges, including infectious, metabolic, and malignant diseases, by combining antibody and small …See details»

Lassogen - Products, Competitors, Financials, Employees, …

Lassogen focuses on biotechnology, specifically in the development of a new class of programmable medicines. The company offers Lassotides, which are optimized lasso peptides …See details»

Lassogen raises $4.5M in seed round to develop novel therapeutics

Combining the power of antibodies and small molecule drugs, the San Diego-based startup Lassogen is developing lasso peptides as a new therapeutic modality.See details»

Lassogen, Inc.

Lassogen is harnessing the untapped power of lasso peptides as a novel modality to treat some of the world’s most challenging diseases. Founded in 2019 by leading figures in biotechnology, …See details»

Lassogen Raises Seed Round to Develop Novel Therapeutics for ...

Oct 13, 2020 · Lassogen is developing a new class of peptide therapeutics that combine the strengths of antibodies and small molecule drugs while overcoming many of their limitations.See details»

Lassogen - Company info. interviews, news - BiopharmaTrend

Lassogen’s cutting-edge platform integrates genomics, advanced synthetic biology, and AI-data analytics to enable accelerated discovery, optimization, and production of our novel lasso …See details»

Target & Pipline - Lassogen

Our lead lassotide displays excellent stability, safety (no immunogenicity or off-target activity), pharmacokinetic properties (in vivo t½ = 7 h in mice), and tissue distribution.See details»

Could a lasso-shaped drug blend the best of antibodies and small ...

Oct 13, 2020 · Lassogen’s goal is to create modular treatments that can be “programmed” for different diseases. Lasso peptides could be particularly useful in targeting GPCRs and …See details»

News & Blogs - lassogen.com

Lassogen Raises Seed Round to Develop Novel Therapeutics for Challenging TargetsSee details»

linkstock.net © 2022. All rights reserved